Semaglutide for MASH: MDs needed to comment Semaglutide is now approved to treat metabolic dysfunction-associated steatohepatitis or MASH. I'm looking for an MD (endocrinologist, general practitioner, or weight loss specialist) to weigh in about how the med can improve/protect liver health and what new users need to know about starting on semaglutide. Expert should be available to answer an email Q&A by Monday 12/1.